Literature DB >> 11390730

An experimental sclerosing encapsulating peritonitis model in mice.

Y Ishii1, T Sawada, A Shimizu, T Tojimbara, I Nakajima, S Fuchinoue, S Teraoka.   

Abstract

BACKGROUND: Sclerosing encapsulating peritonitis (SEP) is a life-threatening complication of continuous ambulatory peritoneal dialysis. To elucidate the mechanism and develop treatments for this condition, an experimental SEP model in mice was constructed.
METHODS: C57BL/6 mice were administered 0.3 ml of 0.1% chlorhexidine gluconate and 15% ethanol dissolved in saline, intraperitoneally, on a daily basis for 56 days (group 1, n=15). A control group of C57BL/6 mice were administered 0.3 ml of phosphate-buffered saline only in the same manner (group 2, n=15). The mice were sacrificed on days 3, 7, 21, 56 and were prepared for histological analysis.
RESULTS: In group 1, all mice had developed macroscopic evidence of SEP 56 days after the injection. Microscopically we observed peritoneal fibrosis and an increase in infiltrates of mononuclear cells over time. The peritoneal fibrosis reached the chronic inflammatory stage by 56 days after the injection.
CONCLUSION: We have developed a convenient experimental model of SEP in mice, which may be useful in elucidating the pathogenesis of SEP and in establishing possible treatments.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390730     DOI: 10.1093/ndt/16.6.1262

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  18 in total

1.  Abatacept as a therapeutic option in the treatment of encapsulated peritoneal sclerosis: an experimental rat model.

Authors:  Latife Bircan; Suleyman Karakose; Hatice Unverdi; Ayşe Zeynep Bal; Selman Unverdi; Murat Duranay
Journal:  Int Urol Nephrol       Date:  2017-02-11       Impact factor: 2.370

2.  The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

Authors:  Bülent Huddam; Murat Başaran; Gülay Koçak; Alper Azak; Funda Yalçın; Nihan Haberal Reyhan; Murat Duranay
Journal:  Int Urol Nephrol       Date:  2015-07-10       Impact factor: 2.370

Review 3.  A review of rodent models of peritoneal dialysis and its complications.

Authors:  Ji Wang; Shujun Liu; Hongyu Li; Jing Sun; Sijin Zhang; Xiaohong Xu; Yingying Liu; Yangwei Wang; Lining Miao
Journal:  Int Urol Nephrol       Date:  2014-11-26       Impact factor: 2.370

4.  Differentiation of bone marrow-derived cells into regenerated mesothelial cells in peritoneal remodeling using a peritoneal fibrosis mouse model.

Authors:  Yoshimi Sekiguchi; Chieko Hamada; Yuuki Ro; Hirotaka Nakamoto; Masanori Inaba; Tetsutaro Shimaoka; Hiroaki Io; Ichiro Koyanagi; Seiki Aruga; Jiro Inuma; Kayo Kaneko; Yoko Hotta; Peter J Margetts; Hideki Mochizuki; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Artif Organs       Date:  2012-05-24       Impact factor: 1.731

5.  Deficiency of endothelial nitric oxide signaling pathway exacerbates peritoneal fibrosis in mice.

Authors:  Hiroyuki Kadoya; Minoru Satoh; Hajime Nagasu; Tamaki Sasaki; Naoki Kashihara
Journal:  Clin Exp Nephrol       Date:  2014-09-13       Impact factor: 2.801

6.  Pyrrole-imidazole polyamide targeting transforming growth factor β1 ameliorates encapsulating peritoneal sclerosis.

Authors:  Kazuo Serie; Noboru Fukuda; Shigeki Nakai; Hiroyuki Matsuda; Takashi Maruyama; Yoshinobu Murayama; Sadao Omata
Journal:  Perit Dial Int       Date:  2012-01-03       Impact factor: 1.756

7.  Hyperspectral evaluation of peritoneal fibrosis in mouse models.

Authors:  Jošt Stergar; Rok Dolenec; Nika Kojc; Katja Lakota; Martina Perše; Matija Tomšič; Matija Milanic
Journal:  Biomed Opt Express       Date:  2020-03-13       Impact factor: 3.732

8.  Activation of p38 mitogen-activated protein kinase promotes peritoneal fibrosis by regulating fibrocytes.

Authors:  Satoshi Kokubo; Norihiko Sakai; Kengo Furuichi; Tadashi Toyama; Shinji Kitajima; Toshiya Okumura; Kouji Matsushima; Shuichi Kaneko; Takashi Wada
Journal:  Perit Dial Int       Date:  2011-06-30       Impact factor: 1.756

9.  Effect of sirolimus on the regression of peritoneal sclerosis in an experimental rat model.

Authors:  Mevlut Ceri; Selman Unverdi; Mehmet Dogan; Hatice Unverdi; Gokhan Karaca; Gulay Kocak; Ilhan Kurultak; Erdem Akbal; Murat Can; Murat Duranay
Journal:  Int Urol Nephrol       Date:  2012-04-15       Impact factor: 2.370

10.  Increased postoperative peritoneal adhesion formation after the treatment of experimental peritonitis with chlorhexidine.

Authors:  Almantas Maleckas; Virmantas Daubaras; Valdas Vaitkus; Albina Aniuliene; Evaldas Dirzinauskas; Mindaugas Rakauskas; Juozas Pundzius
Journal:  Langenbecks Arch Surg       Date:  2004-05-25       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.